Cargando…

Replication-Competent ΔNS1 Influenza A Viruses Expressing Reporter Genes

The influenza A virus (IAV) is able to infect multiple mammalian and avian species, and in humans IAV is responsible for annual seasonal epidemics and occasional pandemics of respiratory disease with significant health and economic impacts. Studying IAV involves laborious secondary methodologies to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nogales, Aitor, Schotsaert, Michael, Rathnasinghe, Raveen, DeDiego, Marta L., García-Sastre, Adolfo, Martinez-Sobrido, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072579/ https://www.ncbi.nlm.nih.gov/pubmed/33920517 http://dx.doi.org/10.3390/v13040698

Ejemplares similares

Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use
por: Nogales, Aitor, et al.
Publicado: (2022)

Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins
por: Nogales, Aitor, et al.
Publicado: (2018)

Natural Selection of H5N1 Avian Influenza A Viruses with Increased PA-X and NS1 Shutoff Activity
por: Nogales, Aitor, et al.
Publicado: (2021)

NS1 Protein Mutation I64T Affects Interferon Responses and Virulence of Circulating H3N2 Human Influenza A Viruses
por: DeDiego, Marta L., et al.
Publicado: (2016)

Replication-Competent Influenza A Viruses Expressing Reporter Genes
por: Breen, Michael, et al.
Publicado: (2016)

Functional Characterization and Direct Comparison of Influenza A, B, C, and D NS1 Proteins in vitro and in vivo
por: Nogales, Aitor, et al.
Publicado: (2019)

Interferon-Induced Protein 44 Interacts with Cellular FK506-Binding Protein 5, Negatively Regulates Host Antiviral Responses, and Supports Virus Replication
por: DeDiego, Marta L., et al.
Publicado: (2019)

Influenza Virus and Vaccination
por: Nogales, Aitor, et al.
Publicado: (2020)

Amino Acid Residues Involved in Inhibition of Host Gene Expression by Influenza A/Brevig Mission/1/1918 PA-X
por: Chiem, Kevin, et al.
Publicado: (2021)

The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Replication-Competent Influenza A and B Viruses Expressing a Fluorescent Dynamic Timer Protein for In Vitro and In Vivo Studies
por: Breen, Michael, et al.
Publicado: (2016)

Host Single Nucleotide Polymorphisms Modulating Influenza A Virus Disease in Humans
por: Nogales, Aitor, et al.
Publicado: (2019)

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
por: Jangra, Sonia, et al.
Publicado: (2021)

The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
por: Jangra, Sonia, et al.
Publicado: (2021)

Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine.
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Reverse Genetics Approaches for the Development of Influenza Vaccines
por: Nogales, Aitor, et al.
Publicado: (2016)

Antigenicity of the 2015–2016 seasonal H1N1 human influenza virus HA and NA proteins
por: Clark, Amelia M., et al.
Publicado: (2017)

Identification of Amino Acid Residues Responsible for Inhibition of Host Gene Expression by Influenza A H9N2 NS1 Targeting of CPSF30
por: Rodriguez, Laura, et al.
Publicado: (2018)

Host-Range Restriction of Vaccinia Virus E3L Deletion Mutant Can Be Overcome In Vitro, but Not In Vivo, by Expression of the Influenza Virus NS1 Protein
por: Guerra, Susana, et al.
Publicado: (2011)

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model
por: Amanat, Fatima, et al.
Publicado: (2020)

Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
por: Amanat, Fatima, et al.
Publicado: (2021)

The IFN-stimulated gene IFI27 counteracts innate immune responses after viral infections by interfering with RIG-I signaling
por: Villamayor, Laura, et al.
Publicado: (2023)

Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine
por: Martínez-Sobrido, Luis, et al.
Publicado: (2018)

Antisense Oligonucleotides Targeting Influenza A Segment 8 Genomic RNA Inhibit Viral Replication
por: Lenartowicz, Elzbieta, et al.
Publicado: (2016)

RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine
por: Jangra, Sonia, et al.
Publicado: (2022)

An Alanine-to-Valine Substitution in the Residue 175 of Zika Virus NS2A Protein Affects Viral RNA Synthesis and Attenuates the Virus In Vivo
por: Márquez-Jurado, Silvia, et al.
Publicado: (2018)

A natural polymorphism in Zika virus NS2A protein responsible of virulence in mice
por: Ávila-Pérez, Gines, et al.
Publicado: (2019)

Interferon alpha inducible protein 6 is a negative regulator of innate immune responses by modulating RIG-I activation
por: Villamayor, Laura, et al.
Publicado: (2023)

Mutations Designed by Ensemble Defect to Misfold Conserved RNA Structures of Influenza A Segments 7 and 8 Affect Splicing and Attenuate Viral Replication in Cell Culture
por: Jiang, Tian, et al.
Publicado: (2016)

Potent Inhibition of Zika Virus Replication by Aurintricarboxylic Acid
por: Park, Jun-Gyu, et al.
Publicado: (2019)

Novel Approaches for The Development of Live Attenuated Influenza Vaccines
por: Blanco-Lobo, Pilar, et al.
Publicado: (2019)

Development of a novel equine influenza virus live-attenuated vaccine
por: Rodriguez, Laura, et al.
Publicado: (2018)

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine
por: Nogales, Aitor, et al.
Publicado: (2022)

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Mammalian Adaptation of an Avian Influenza A Virus Involves Stepwise Changes in NS1
por: Chauché, C., et al.
Publicado: (2018)

Human interactome of the influenza B virus NS1 protein
por: Patzina, Corinna, et al.
Publicado: (2017)

Influenza Vaccines: A Moving Interdisciplinary Field
por: Schotsaert, Michael, et al.
Publicado: (2014)

A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines
por: White, Chantelle L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fi2tp24e1fsgoot8hjla64fidj